Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 74
Filter
1.
Int J Tuberc Lung Dis ; 20(2): 211-7, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26792473

ABSTRACT

SETTING: An Hoa Clinic, a district-level human immunodeficiency virus (HIV) clinic in Ho Chi Minh City, Viet Nam. OBJECTIVE: To assess the performance of chest radiograph (CXR) in screening for pulmonary tuberculosis (PTB) among HIV-infected individuals and identify misdiagnosed opportunities. DESIGN: This cross-sectional study was conducted in 397 HIV-infected patients consecutively enrolled at the An Hoa Clinic in Ho Chi Minh City, Viet Nam, from August 2009 to June 2010. The performance of CXR in TB screening was assessed based on its sensitivity, specificity, positive likelihood ratio and negative likelihood ratio. RESULTS: Symptom screening alone missed 50% of PTB cases. The combination of CXR and symptom screening yielded an additional 28.6% (8/28) in PTB screening as compared with symptom screening alone, and should be applied routinely, especially in high TB prevalent settings. CONCLUSION: CXR is a good predictor for PTB even in HIV-infected individuals. The combination of CXR and screening for common TB symptoms considerably improved the sensitivity of detecting active PTB in people living with HIV. If available, routine sputum culture and the World Health Organization-endorsed Xpert(®) MTB/RIF assay should be implemented to achieve a more accurate diagnosis.


Subject(s)
Ambulatory Care Facilities , Coinfection , HIV Infections/epidemiology , Radiography, Thoracic , Tuberculosis, Pulmonary/diagnostic imaging , Adolescent , Adult , Cross-Sectional Studies , Diagnostic Errors , Female , HIV Infections/diagnosis , HIV Infections/therapy , Humans , Likelihood Functions , Male , Middle Aged , Predictive Value of Tests , Prevalence , Prognosis , Reproducibility of Results , Tuberculosis, Pulmonary/epidemiology , Vietnam/epidemiology , Young Adult
2.
Int J STD AIDS ; 23(11): 792-8, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23155099

ABSTRACT

While the association between smoking and human papillomavirus infection, cervical cancer, and anal cancer has been well studied, evidence on the association between cigarette smoking and anal warts is limited. The purpose of this study was to investigate if cigarette smoking status influences the size of anal warts over time in HIV-infected women in a sample of 976 HIV-infected women from the Women's Interagency HIV Study (WIHS). A linear mixed model was used to determine the effect of smoking on anal wart size. Even though women who were currently smokers had larger anal warts at baseline and slower growth rate of anal wart size after each visit than women who were not current smokers, there was no association between size of anal wart and current smoking status over time. Further studies on the role of smoking and interaction between smoking and other risk factors, however, should be explored.


Subject(s)
Anus Neoplasms/epidemiology , Anus Neoplasms/pathology , HIV Infections/complications , Smoking/adverse effects , Warts/epidemiology , Warts/pathology , Adult , Aged , Female , Humans , Middle Aged , Young Adult
3.
Int J Tuberc Lung Dis ; 15(11): 1528-34, i, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22008768

ABSTRACT

SETTING: District 6, An Hoa Clinic in Ho Chi Minh City (HCMC), Viet Nam. OBJECTIVE: To evaluate the performance of various algorithms in tuberculosis (TB) screening and diagnosis in a human immunodeficiency virus (HIV) infected population in HCMC, Viet Nam. DESIGN: A cross-sectional study of 397 consecutive HIV-infected patients seeking care at the An Hoa Clinic from August 2009 to June 2010. Data on participant demographics, clinical status, chest radiography (CXR) and laboratory results were collected. A multiple logistic regression model was developed to assess the association of covariates and pulmonary TB (PTB). RESULTS: The prevalence of sputum culture-confirmed PTB, acid-fast bacilli (AFB) positive TB, and multidrugresistant TB among the 397 HIV-infected patients was respectively 7%, 2%, and 0.3%. Adjusted odds ratios for low CD4+ cell count, positive sputum smear, and CXR to positive sputum culture were respectively 3.17, 32.04 and 4.28. Clinical findings alone had poor sensitivity, but combining CD4+ cell count, AFB sputum smear and CXR had a more accurate diagnostic performance. CONCLUSION: Results suggest that symptom screening had poor clinical performance, and support the routine use of sputum culture to improve the detection of TB disease in HIV-infected individuals in Viet Nam. However, when routine sputum culture is not available, an algorithm combining CD4+ cell count, AFB sputum smear and CXR is recommended for diagnosing PTB.


Subject(s)
AIDS-Related Opportunistic Infections/diagnosis , Coinfection/diagnosis , HIV Infections/diagnosis , Mass Screening , Tuberculosis, Pulmonary/diagnosis , Urban Health Services , AIDS-Related Opportunistic Infections/epidemiology , Adult , Algorithms , CD4 Lymphocyte Count , Coinfection/epidemiology , Cross-Sectional Studies , Female , HIV Infections/epidemiology , Humans , Logistic Models , Male , Mass Screening/methods , Mycobacterium tuberculosis/isolation & purification , Odds Ratio , Predictive Value of Tests , Prevalence , Radiography, Thoracic , Sputum/microbiology , Tuberculosis, Pulmonary/epidemiology , Urban Health Services/statistics & numerical data , Vietnam/epidemiology
4.
J Clin Gastroenterol ; 33(2): 123-6, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11468438

ABSTRACT

BACKGROUND: Egypt has one of the highest prevalence rates of hepatitis C virus (HCV) infection in the world; however, the risk and attribution related to HCV in Egyptian patients with hepatocellular carcinoma (HCC) remains unknown. GOALS: The current study was undertaken to estimate the risk of HCC in relation to HCV in Egypt. STUDY: Thirty-three patients with HCC and 35 healthy controls who had a similar socioeconomic status were prospectively enrolled at the University of Cairo National Cancer Institute. RESULTS: Anti-HCV antibodies were present in 75.8% of the patients and in 42.9% of the controls (p = 0.01); hepatitis B surface antigen (HBsAg) was present in 15.2% of the patients and in 2.9% of the controls (p = 0.03). In addition, the sex-and age-adjusted odds ratio (OR) for anti-HCV antibodies was 5.1 (95% CI = 1.5-17.4) and for HBsAg was 13.2 (95% CI = 1.2-148.2). Concurrent Schistosoma mansoni and anti-HCV was associated with an OR of 10.3 (95% CI = 1.3-79.8), which was higher than that for anti-HCV (6.5; 95% CI = 1.6-26.6) and S. mansoni infection (0.2; 95% CI = 0.1-6.2) alone. Finally, we estimated the attributable fraction of HCC to HCV to be 64% in this study population and 48% in the general Egyptian population. CONCLUSIONS: Both HCV and hepatitis B virus infection increase the risk of HCC in Egyptian patients, whereas isolated Schistosoma infection does not. Because of the very high prevalence rate of HCV in the general Egyptian population, it accounts for most HCC cases in Egypt.


Subject(s)
Carcinoma, Hepatocellular/virology , Hepatitis C, Chronic/diagnosis , Liver Neoplasms/virology , Adult , Aged , Antibodies, Helminth/blood , Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/immunology , Case-Control Studies , Comorbidity , Egypt , Female , Hepatitis B Surface Antigens/blood , Hepatitis B, Chronic/diagnosis , Hepatitis B, Chronic/immunology , Hepatitis C Antibodies/blood , Hepatitis C, Chronic/immunology , Humans , Liver Neoplasms/diagnosis , Liver Neoplasms/immunology , Male , Middle Aged , Prospective Studies , Risk Factors , Schistosomiasis mansoni/diagnosis , Schistosomiasis mansoni/immunology
5.
J Infect Dis ; 179(6): 1319-25, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10228050

ABSTRACT

The long-term efficacy of hepatitis B vaccination among high-risk infants was determined in 805 vaccine responders, immunized at birth in Taiwan during 1981-1984 and followed to age 10 years, via life table survival and Cox multivariate analyses. At 10 years, cumulative persistence of antibody to hepatitis B surface antigen (anti-HBs) was 85%, and cumulative incidence of hepatitis B virus (HBV) infection was 15%. Three children became carriers. Twelve-month anti-HBs titer was the strongest predictor of efficacy. The higher the initial titer, the lower the risk of anti-HBs loss (relative risk [RR], 0.26 for titer of 100-999 mIU/mL; RR, 0.08 for titer >1000 mIU/mL; P<.001) and HBV infection (RR, 0.55 and 0.27; P<.05). Maternal hepatitis B e antigen positivity but not hepatitis B immunoglobulin dose or gender predicted greater antibody persistence to age 10 years. Because the level of antibody persistence remained high and few became carriers, booster revaccination within 10 years seems unnecessary.


Subject(s)
Hepatitis B Vaccines/therapeutic use , Hepatitis B/prevention & control , Vaccination , Child , Child, Preschool , Female , Follow-Up Studies , Hepatitis B/epidemiology , Hepatitis B Antibodies/blood , Hepatitis B Surface Antigens/immunology , Hepatitis B e Antigens/blood , Humans , Incidence , Infant , Infectious Disease Transmission, Vertical , Male , Multivariate Analysis , Risk , Taiwan/epidemiology
6.
Int J Cancer ; 77(6): 811-6, 1998 Sep 11.
Article in English | MEDLINE | ID: mdl-9714045

ABSTRACT

We have investigated the familial aggregation of colorectal cancer and hereditary nonpolyposis colorectal cancer (HNPCC) in Egypt because of the high incidence of colorectal cancer in Egyptian children and young adults and the prevalence of consanguinity there. In a pilot study, we conducted detailed interviews with 111 Egyptian colorectal cancer patients and 111 healthy Egyptian controls about their family histories of colorectal cancer, and other cancers, consanguinity, age at diagnosis, symptoms and recurrence. Eight patients (7.2%) had one or more first- or second-degree relatives under age 40 with colorectal cancer, suggestive of HNPCC by the Amsterdam criteria. One of these families had a typical history of HNPCC, with 4 relatives having colorectal cancer in 3 generations; 3 of these relatives were younger than age 45 at colon cancer diagnosis, and other relatives had extracolonic tumors. Another 14 patients (12.6%) had a first- or second-degree relative with a family history of other neoplasms such as endometrial, urinary and hepatobiliary cancers that could also be related to HNPCC. Four patients with early-onset colon cancer and a family history of other HNPCC-related cancers reported that their parents were first-degree cousins.


Subject(s)
Colorectal Neoplasms/epidemiology , Colorectal Neoplasms/genetics , Adolescent , Adult , Aged , Case-Control Studies , Colorectal Neoplasms, Hereditary Nonpolyposis/epidemiology , Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , Egypt/epidemiology , Female , Humans , Male , Middle Aged , Pedigree , Pilot Projects , Surveys and Questionnaires
7.
Cancer Epidemiol Biomarkers Prev ; 7(7): 567-70, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9681523

ABSTRACT

Although the pathogenesis of hepatocellular carcinoma (HCC) remains poorly understood, hepatitis B virus and dietary aflatoxin exposures are established etiological factors for this disease. We conducted a pilot study of 28 patients with HCC and 110 healthy controls matched for age, sex, and ethnicity to determine whether constitutional genetic instability, based on the quantification of mutagen-induced chromatid breaks in cultured lymphocytes, modifies an individual's risk of HCC development. The mean numbers of bleomycin-induced breaks per cell for cases and controls were 0.92 and 0.55, respectively (P < 0.0001). For benzo(a)pyrene diol epoxide (BPDE) sensitivity, the values were 0.90 for cases and 0.46 for controls (P < 0.0001). Nearly 68% of the cases but only 27% of the controls exhibited bleomycin sensitivity (i.e., had > or = 0.68 breaks per cell). Eighty % of the case group but only 22% of the control group exhibited BPDE sensitivity (i.e., had > or = 0.58 breaks per cell). On multivariate analyses, both bleomycin sensitivity and BPDE sensitivity were associated with significantly elevated risks for HCC, with odds ratios (95% confidence intervals) of 5.63 (2.30, 13.81) and 14.13 (3.52, 56.68), respectively. For individuals who were sensitive to both assays, the risk was 35.88. A synergistic interaction between the bleomycin sensitivity and BPDE sensitivity in HCC risk was suggested. These preliminary findings suggest that differences in host factors related to the predisposition to chromosome breakage, the capacity for DNA repair, or both may be involved in HCC development by influencing the predisposition of hepatitis B virus integration into human DNA or that the carcinogens induced DNA damage susceptibility. A larger study is needed to confirm these intriguing results.


Subject(s)
Carcinoma, Hepatocellular/genetics , Chromatids/drug effects , DNA Damage , Liver Neoplasms/genetics , 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide , Antibiotics, Antineoplastic/toxicity , Bleomycin/toxicity , Case-Control Studies , DNA Repair , Disease Susceptibility , Female , Humans , Lymphocytes/drug effects , Male , Middle Aged , Mutagenicity Tests , Mutagens , Pilot Projects
8.
Int J Oncol ; 12(6): 1315-9, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9592192

ABSTRACT

An Egyptian hospital-based pilot case-control study was conducted to investigate the relationship between the expression level of mismatch repair (MMR) genes and the risk of colorectal cancer. The relative expression of five known MMR genes, i.e., hMSH2, hMLH1, hPMS1, hPMS2, and GTBP/hMSH6, was measured by a multiplex reverse transcriptase (RT)-polymerase chain reaction (PCR) in peripheral blood lymphocytes from 31 colorectal cancer patients and 47 age- and-sex matched controls. The expression of hMSH2, GTBP/hMSH6, hPMS1 and hPMS2 tended to be lower in patients than controls, but only the difference in hPMS2 expression was statistically significant (p<0. 01). Although 50% of the cases had chemotherapy or radiotherapy within the last six months before the blood was drawn, their gene expression was not statistically different from those who had not undergone such therapies. After adjustment for age and sex, the odds ratios (OR) calculated from a logistical regression model, using the median levels of gene expression of controls as cut-off values, indicated that increased risk was associated with reduced expressions of both hPMS1 (OR = 3.97, 95% confidence interval (CI) = 1.04 to 7.65) and hPMS2 (OR = 2.86, 95% CI = 1.05 to 7.76). Although the results of this study were inconclusive because of the small sample size and use of prevalent cases, it is biologically plausible that patients with colorectal cancers may have a lower expression of MMR genes than healthy controls because malfunction of these genes has been shown in hereditary nonpolyposis colon cancer. The involvement of low hPMS2 expression in colon cancer risk seems to be unique in the Egyptian population. Further studies with newly diagnosed patients before they begin therapy will provide more convincing data about the role of MMR gene expression in the etiology of colorectal cancers in Egypt.


Subject(s)
Adenosine Triphosphatases , Colorectal Neoplasms/genetics , DNA Repair Enzymes , DNA Repair/genetics , Genes, Neoplasm/genetics , Adaptor Proteins, Signal Transducing , Adult , Age Factors , Carrier Proteins , Colorectal Neoplasms/epidemiology , DNA-Binding Proteins/genetics , Egypt/epidemiology , Female , Gene Expression/genetics , Humans , Logistic Models , Male , Middle Aged , Mismatch Repair Endonuclease PMS2 , MutL Protein Homolog 1 , MutL Proteins , MutS Homolog 2 Protein , Neoplasm Proteins/genetics , Nuclear Proteins , Proto-Oncogene Proteins/genetics , Risk Factors , Sex Factors
9.
Int J Cancer ; 71(1): 26-30, 1997 Mar 28.
Article in English | MEDLINE | ID: mdl-9096661

ABSTRACT

Although colorectal cancer is not a common cancer in Egypt, the age distribution of the disease shows that a high proportion occurs in children and adults under 40 years of age. We reviewed the records of 1,608 colorectal cancer patients treated in 4 cancer hospitals in Egypt during a period of 3 to 10 years. The hospitals in which about 85% of all colorectal cancer cases in Egypt were seen included Egypt's 2 major cancer centers, The National Cancer Institute (NCI) in Cairo and Tanta Cancer Center (TCC) in the mid-Nile Delta region, and 2 major university hospitals, Assiut University in South Egypt and Ain Shams University in Cairo. Our review showed that patients younger than 40 years represented 35.6% of all patients in the 4 cancer hospitals, and that these rates were similar among the hospitals and for the years reviewed. The male-to-female ratio increased from 1.0 to 1.7 for the age groups ranging from 0-9 and 30-39 years, and increased from 1.0 to 1.5 for the age groups ranging from 40-49 to over 60 years. More than half of all the patients had rectal tumors, and about 90% of the cancers were adenocarcinomas; 30.6% of patients younger than 40 years, compared with 13.8% of older patients, had mucin-producing tumors. This study confirmed the occurrence of a high colorectal cancer rate in young Egyptians, and it opens the door to future epidemiologic studies to identify causes and risk factors of this disease pattern in Egypt.


Subject(s)
Colorectal Neoplasms/epidemiology , Adenocarcinoma/epidemiology , Adolescent , Adult , Age Factors , Child , Child, Preschool , Egypt/epidemiology , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged
10.
J Infect Dis ; 170(6): 1418-23, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7995980

ABSTRACT

To evaluate the role of maternal hepatitis B virus (HBV) DNA levels in perinatal infection, two nested case-control studies were done within a cohort of 773 hepatitis B surface antigen (HBsAg)-positive Taiwanese women and their infants. As serum HBV DNA levels increased from < 0.005 to > or = 1.4 ng/mL among the hepatitis B e antigen (HBeAg)-positive mothers, the odds ratio (OR) for having a persistently infected infant increased from 1.0 to 147.0 (P for trend < .001). Among HBeAg-negative mothers, the OR for having a persistently infected infant was 19.2 (95% confidence interval, 2.3-176.6) in mothers with high versus low levels of serum HBV DNA. A logistic regression analysis identified maternal HBV DNA to be a stronger independent predictor of persistent infection than HBeAg status. Thus, perinatal exposure to high levels of maternal HBV DNA is the most important determinant of infection outcome in the infant.


Subject(s)
DNA, Viral/blood , Hepatitis B e Antigens/blood , Hepatitis B virus/physiology , Hepatitis B/transmission , Hepatitis B/virology , Infectious Disease Transmission, Vertical , Case-Control Studies , Chronic Disease , Cohort Studies , Female , Hepatitis B Antibodies/blood , Hepatitis B Surface Antigens/blood , Humans , Incidence , Infant, Newborn , Odds Ratio , Regression Analysis , Taiwan
12.
J Med Virol ; 27(4): 269-73, 1989 Apr.
Article in English | MEDLINE | ID: mdl-2542436

ABSTRACT

A serological survey using antibody to Epstein-Barr virus (EBV)-specific DNase activity as a marker for the identification of patients with nasopharyngeal carcinoma (NPC) has been carried out on healthy subjects who visited Government Employees' Clinic Center (GECC) for routine health examination and on individuals residing in NPC high-risk areas (HRA) in Taiwan. During a 3-year prospective study, 22,596 and 9,869 sera were collected from the GECC and HRA groups, respectively. Taking neutralization of 2 or more units of EBV DNase activity as a positive response, the positivity rates in the GECC and HRA groups were 5.4% and 11.92%, respectively. Among the antibody-positive individuals, three cases of NPC were found in the GECC group (detection rate 0.63%) and 11 in the HRA group (detection rate 1.32%). A further patient at stage III of the disease was found in the first year of following up of 1,005 antibody-positive individuals. Among the 12 NPC patients in the HRA, five were newly diagnosed as having stage II (three patients) and stage III (two patients) NPC. These results support the hypothesis that antibody against EBV-specific DNase activity may be a useful marker for detection of patients with NPC, and they imply that individuals having high levels of antibody to EBV DNase activity may have an increased risk of development of NPC.


Subject(s)
Antibodies, Viral/analysis , Biomarkers, Tumor/immunology , Carcinoma/immunology , Deoxyribonucleases/immunology , Herpesvirus 4, Human/immunology , Nasopharyngeal Neoplasms/immunology , Adult , Aged , Carcinoma/microbiology , Cross-Sectional Studies , Data Collection , Evaluation Studies as Topic , Female , Follow-Up Studies , Herpesvirus 4, Human/enzymology , Humans , Immunoglobulin A/analysis , Immunoglobulin A/immunology , Male , Middle Aged , Nasopharyngeal Neoplasms/epidemiology , Nasopharyngeal Neoplasms/microbiology , Prospective Studies , Taiwan
13.
Transfusion ; 29(2): 113-8, 1989 Feb.
Article in English | MEDLINE | ID: mdl-2919421

ABSTRACT

To determine the incidence of transfusion-associated human immunodeficiency virus (HIV) infection after routine screening of donated blood, a pilot study estimated the pretransfusion prevalence of HIV infection among blood product recipients in San Francisco. Among the 911 nonduplicate pretransfusion specimens from recipients without a clinical history of acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC), the overall prevalence of antibody to HIV was 2.9 percent (5.2% among males and 0.6% among females; p = 0.00002). If recipients in specifically defined or possible high-risk groups (n = 348) were excluded, a seropositivity rate of 1.8 percent (10/563) was detected, with all the positives occurring in men (10/242, 4.1%) and none in women (0/321, 0%). This demonstrated prevalence of HIV infection among blood product recipients in San Francisco before transfusion was substantially higher than the known 0.02 to 0.04 percent prevalence in the donor population. Therefore, the population of women without known risk for AIDS is the best in which to assess the risk of HIV infection in patients who are currently receiving seronegative blood transfusions.


Subject(s)
Blood Transfusion , HIV Antibodies/analysis , HIV Seropositivity/epidemiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Blood Specimen Collection , Child , Child, Preschool , Evaluation Studies as Topic , Female , HIV Seropositivity/transmission , Humans , Infant , Infant, Newborn , Male , Middle Aged , Pilot Projects , Reference Standards , Risk Factors , San Francisco , Sex Factors , Time Factors
14.
Am J Epidemiol ; 128(4): 828-38, 1988 Oct.
Article in English | MEDLINE | ID: mdl-3421246

ABSTRACT

The authors determined the age-specific prevalence of hepatitis B virus markers in 1,408 Chinese who resided in South Africa in 1983-1985. The small South African Chinese community consists of original Chinese settlers, almost all of whom migrated from the hepatitis B virus endemic mainland China province of Guangdong, and their South African-born descendants. The Chinese live among the white South African community, which has a very low hepatitis B virus carrier rate. The overall hepatitis B virus carrier rate was 5.3%, and the carrier rate was highest in age group 30-39 years (11.9%) and significantly lower in children aged 1-9 and 10-19 years (2.4% and 2.0%, respectively). Overall infection rates increased progressively with increasing age, starting at about 10% in the children aged 1-19 years and reaching 50% in adults aged 60-69 years. Among carrier children, 89% had carrier mothers, and all of the latter were also hepatitis e antigen (HBeAg)-positive. The prevalence of hepatitis B virus carriers in South African Chinese women of child-bearing age was 6.1%, and 41.9% of these carriers were HBeAg-positive. The age-specific prevalence of hepatitis B virus markers among South African Chinese is appreciably lower than that of Chinese in southeastern China, who have carrier rates of 15-20% with a peak in childhood. The prevalence of hepatitis B virus infection appears to be decreasing in South African Chinese, probably because improved hygienic and socioeconomic circumstances, in comparison with those in Guangdong, have resulted in less horizontal transmission of the virus. A diminishing pool of carriers is maintained by perinatal maternal-infant infection.


Subject(s)
Carrier State/ethnology , Hepatitis B/ethnology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Child , Child, Preschool , China/ethnology , Epidemiologic Methods , Female , Humans , Infant , Male , Middle Aged , Sex Factors , South Africa
16.
Hepatology ; 8(2): 374-7, 1988.
Article in English | MEDLINE | ID: mdl-3356419

ABSTRACT

Liver histologic findings were studied in 18 children who were 4 to 9 years old, and who had been HBsAg carriers since having been infected by their mothers in the perinatal period. All were born to HBeAg-HBsAg carrier mothers; the children were followed periodically from birth. Throughout their entire course, none developed symptoms or signs suggestive of liver disease. All of the 18 children showed mild but definite liver histologic changes: 15 had nonspecific histologic changes, and three had chronic persistent hepatitis. In 13 of 18 children, follow-up aminotransferase activities were abnormal, but none exceeded 100 KU. At the time of biopsy, ALTs on four children were above the upper limit of normal. All children were HBeAg-positive in early infancy, but five lost this antigen and developed antibody during follow-up. The histologic findings in HBeAg-positive children did not differ from those in children with antibody. Perinatal hepatitis B virus infection has been thought to play an important role in chronic liver disease, including hepatocellular carcinoma. This study indicates that some pathologic changes following perinatal infection begin very early.


Subject(s)
Carrier State , Hepatitis B Surface Antigens/analysis , Hepatitis B/transmission , Liver/pathology , Postpartum Period , Alanine Transaminase/blood , Biopsy , Child , Child, Preschool , Female , Humans , Infant, Newborn , Male , Pregnancy , Prospective Studies
17.
Acta Chir Scand ; 154(3): 199-203, 1988 Mar.
Article in English | MEDLINE | ID: mdl-2837031

ABSTRACT

Fifty-one patients with histologically proven small (less than 5 cm) hepatocellular carcinoma underwent hepatic resection. In ten cases (group A) the cancer cells were confined within the tumor capsule, in ten (group B) there was extracapsular extension of growth, in 23 (group C) there was also invasion of the portal vein from the main tumor or from satellite nodules, or both, and in eight cases (group D) the findings were the same as in group C but there was no tumor capsule. The mean follow-up period was 54 +/- 12 months, minimum 37 months. The estimated 7-year survival rates in groups A-D were, respectively 100, 47.5, 47.5 and 37.5%. The classification of gross tumor appearance as typical or atypical was fairly well correlated to the histologic pattern in groups A, C and D, but not in group B. Although safety margin at resection did not emerge as a prognostic factor, the group A patients with a good margin were free from tumour recurrence.


Subject(s)
Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Aged , Carcinoma, Hepatocellular/surgery , Female , Follow-Up Studies , Humans , Liver Neoplasms/surgery , Male , Middle Aged , Neoplasm Recurrence, Local , Prognosis
18.
J Hepatol ; 5(3): 268-73, 1987 Dec.
Article in English | MEDLINE | ID: mdl-2828462

ABSTRACT

The sera of apparently healthy carriers of hepatitis B virus surface antigen enrolled in the Taiwan Prospective Study were tested retrospectively for anti-HBc IgM, to determine whether this test would be useful in predicting the development of hepatocellular carcinoma (HCC) and/or cirrhosis. In comparison with men who did not develop HCC or cirrhosis, the relative risk of those with anti-HBc IgM elevations was 3.4 and 5.6, respectively. Each of these factors was highly statistically significant, although the difference between them was not. Demonstration of anti-HBc IgM titers of greater than 1:1000 in serum probably reflects ongoing low level viral replication but not recent infection. Anti-HBc IgM appears to be a useful prognostic indicator for the future development of HCC and/or cirrhosis.


Subject(s)
Carcinoma, Hepatocellular/immunology , Hepatitis B Antibodies/analysis , Hepatitis B Core Antigens/immunology , Immunoglobulin M/analysis , Liver Cirrhosis/etiology , Liver Neoplasms/immunology , Adult , Aged , Carcinoma, Hepatocellular/complications , Female , Hepatitis B Surface Antigens/immunology , Humans , Liver Neoplasms/complications , Male , Middle Aged , Prospective Studies , Retrospective Studies , Risk Factors , Taiwan
20.
Br J Cancer ; 54(5): 779-85, 1986 Nov.
Article in English | MEDLINE | ID: mdl-2432915

ABSTRACT

Alpha-foetoprotein (AFP) synthesis, although repressed in normal adults, is increased in the majority of patients with hepatocellular carcinoma (HCC). We have investigated whether active transcription of the AFP gene may explain raised serum AFP concentrations in patients with HCC and hepatoblastoma by assaying human tumour and non-neoplastic tissue by molecular hybridization for the presence of mRNA encoding AFP. Ten operative HCC and six autopsy HCC specimens, two HCC cell lines, and one hepatoblastoma specimen were examined. Total cellular RNA and poly-(A)+ RNA were extracted and AFP mRNA sequences sought by dot-blot and Northern blot hybridisation to a human cDNA AFP probe. Cellular AFP was localised by avidin-biotin staining. AFP mRNA was detected in 8/10 operative specimens, as well as PLC/PRF/5 nude mouse tumours. Weaker hybridization was detected in 4/6 autopsy specimens. Signals of comparable intensity to that in operative tumours were detected in non-neoplastic tissue of 6 patients. AFP mRNA from nude mouse tumours migrated as a 20S discrete band on agarose gel electrophoresis, whereas a more complex hybridization pattern was evident in human tumours. Positive cytoplasmic immuno-staining for AFP was observed in 4 tumours and 2 corresponding non-neoplastic specimens and in a HCC cell line. In non-neoplastic liver, AFP was localised in cells that appeared dysplastic. Thus steady-state levels of AFP mRNA are detectable in human HCC tissue and surrounding non-neoplastic liver. These findings may prove pertinent to an understanding of the genetic expression of AFP in malignant hepatocytes, and the sequence of events leading to uncontrolled cellular proliferation.


Subject(s)
Carcinoma, Hepatocellular/metabolism , Liver Neoplasms/metabolism , RNA, Messenger/analysis , alpha-Fetoproteins/biosynthesis , Electrophoresis, Agar Gel , Humans , Nucleic Acid Hybridization , Ribonucleotides/analysis , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...